PA
TTI icon

PharVision Advisers’s TETRA Technologies TTI Stock Holding History

PharVision Advisers’s Portfolio TTI Stock Details TTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,151
Closed -$123K – 609
2025
Q4 		$123K Sell
13,151
-829
-6% -$6.4K 0.06% 639
2025
Q3 		$80.4K Buy
+13,980
New +$59.7K 0.05% 637

Other funds holding TTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

PharVision Advisers's TTI Position: Q1 2026 in Review

PharVision Advisers sold out of TETRA Technologies (TTI) in Q1 2026, closing a stake of 13,151 shares — an estimated $123K sold.

PharVision Advisers first reported a position in TTI in Q3 2025 and held it in 2 quarters. The position peaked at $123K in Q4 2025. 240 funds tracked by Wall St. Rank hold TTI as of Q1 2026.

  • PharVision Advisers reported no remaining TETRA Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 13,151 TETRA Technologies shares in Q1 2026, an estimated $123K.
  • PharVision Advisers first reported a position in TETRA Technologies in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's TETRA Technologies position peaked at $123K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held TETRA Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.